Skip to main content
Top
Published in: Journal of Nuclear Cardiology 6/2016

01-12-2016 | Editorial

Why LV dilatation with vasodilator stress in hypertrophic cardiomyopathy?

Author: Richard C. Brunken, MD, FACC, FAHA, FASNC

Published in: Journal of Nuclear Cardiology | Issue 6/2016

Login to get access

Excerpt

Transient ischemic dilatation (TID) of the left ventricle (LV) on vasodilator stress perfusion images is a concerning sign. In some, TID may reflect global subendocardial hypoperfusion during stress.1 A reduction in subendocardial perfusion results in an increase in observed chamber size on the stress images and the finding of TID. However, in patients with advanced coronary disease (CAD), TID during vasodilator stress might also reflect transient LV dysfunction due to generation of an actual myocardial oxygen supply/demand imbalance (true ischemia). TID on vasodilator stress PET perfusion images has previously been correlated with impaired myocardial perfusion reserve and with an acute decline in LV systolic function during stress.2 Moreover, patients with TID on vasodilator PET images exhibit poorer clinical outcomes as compared to those without TID who have similar LV ejection fractions and perfusion defect scores.3 Thus, TID on vasodilator stress images in CAD patients may reflect global subendocardial hypoperfusion, induction of a true oxygen supply/demand imbalance with ischemic LV dysfunction, or both. …
Literature
1.
go back to reference Iskandrian AS, Heo J, Nguyen T, Lyons E, Paugh E. Left ventricular dilatation and pulmonary thallium uptake after single-photon emission computer tomography using thallium-201 during adenosine-induced coronary hyperemia. Am J Cardiol 1990;66:807-11.CrossRefPubMed Iskandrian AS, Heo J, Nguyen T, Lyons E, Paugh E. Left ventricular dilatation and pulmonary thallium uptake after single-photon emission computer tomography using thallium-201 during adenosine-induced coronary hyperemia. Am J Cardiol 1990;66:807-11.CrossRefPubMed
2.
go back to reference Van Tosh A, Votaw JR, Reichek N, Palestro CJ, Nichols KJ. The relationship between ischemia-induced left ventricular dysfunction, coronary flow reserve, and coronary steal on regadenoson stress-gated 82Rb PET myocardial perfusion imaging. J Nucl Cardiol 2013;20:1060-8.CrossRefPubMedPubMedCentral Van Tosh A, Votaw JR, Reichek N, Palestro CJ, Nichols KJ. The relationship between ischemia-induced left ventricular dysfunction, coronary flow reserve, and coronary steal on regadenoson stress-gated 82Rb PET myocardial perfusion imaging. J Nucl Cardiol 2013;20:1060-8.CrossRefPubMedPubMedCentral
3.
go back to reference Rischpler C, Higuchi T, Fukushima K, Javadi MS, Merrill J, Nekolla SG, et al. Transient ischemic dilatation ratio in 82Rb PET myocardial perfusion imaging: Normal values and significance as a diagnostic and prognostic marker. J Nucl Med 2012;53:723-30.CrossRefPubMed Rischpler C, Higuchi T, Fukushima K, Javadi MS, Merrill J, Nekolla SG, et al. Transient ischemic dilatation ratio in 82Rb PET myocardial perfusion imaging: Normal values and significance as a diagnostic and prognostic marker. J Nucl Med 2012;53:723-30.CrossRefPubMed
4.
go back to reference Bravo PE, Pinheiro A, Higuchi T, Rischpler C, Merrill J, Santaularia-Tomas M, et al. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy. J Nucl Med 2012;53:407-14.CrossRefPubMed Bravo PE, Pinheiro A, Higuchi T, Rischpler C, Merrill J, Santaularia-Tomas M, et al. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy. J Nucl Med 2012;53:407-14.CrossRefPubMed
5.
go back to reference Bravo PE, Tahari A, Pozios I, Luo H, Bengel FM, Wahl RL, Abraham MR and Abraham TP. Apparent left ventricular cavity dilatation during PET/CT in hypertrophic cardiomyopathy: clinical predictors and potential mechanisms. J Nucl Cardiol 2015. doi:10.1007/s12350-015-0158-8. Bravo PE, Tahari A, Pozios I, Luo H, Bengel FM, Wahl RL, Abraham MR and Abraham TP. Apparent left ventricular cavity dilatation during PET/CT in hypertrophic cardiomyopathy: clinical predictors and potential mechanisms. J Nucl Cardiol 2015. doi:10.​1007/​s12350-015-0158-8.
6.
go back to reference Holly TA, Abbott BG, Al-mallah M, Calnon DA, Cohen M, DiFilippo FP, et al. ASNC Imaging Guidelines for Nuclear Cardiology Procedures. Single photon-emission computed tomography. J Nucl Cardiol 2010;17:941-73.CrossRefPubMed Holly TA, Abbott BG, Al-mallah M, Calnon DA, Cohen M, DiFilippo FP, et al. ASNC Imaging Guidelines for Nuclear Cardiology Procedures. Single photon-emission computed tomography. J Nucl Cardiol 2010;17:941-73.CrossRefPubMed
7.
go back to reference Cannon RO 3rd, Rosing DR, Maron BJ, Leon MB, Bonow RO, Watson RM, Epstein SE. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 1985;71:234-43.CrossRefPubMed Cannon RO 3rd, Rosing DR, Maron BJ, Leon MB, Bonow RO, Watson RM, Epstein SE. Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 1985;71:234-43.CrossRefPubMed
8.
go back to reference Camici P, Chiriatti G, Lorenzoni R, Bellina RC, Gistri R, Italiani G, et al. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: A study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991;17:879-86.CrossRefPubMed Camici P, Chiriatti G, Lorenzoni R, Bellina RC, Gistri R, Italiani G, et al. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: A study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991;17:879-86.CrossRefPubMed
9.
go back to reference Cecchi F, Olivotto I, Gistri R, Lorenzini R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027-35.CrossRefPubMed Cecchi F, Olivotto I, Gistri R, Lorenzini R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027-35.CrossRefPubMed
10.
go back to reference Timmer SAJ, Knaapen P. Coronary microvascular function, myocardial metabolism, and energetics in hypertrophic cardiomyopathy: insights from positron emission tomography. Eur Heart J Cardiovasc Imaging 2013;14:95-101.CrossRefPubMed Timmer SAJ, Knaapen P. Coronary microvascular function, myocardial metabolism, and energetics in hypertrophic cardiomyopathy: insights from positron emission tomography. Eur Heart J Cardiovasc Imaging 2013;14:95-101.CrossRefPubMed
11.
go back to reference Peterson SE, Jerosch-Herold M, Hudsmith LE, Robson MD, Frances JM, Doll HA, et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 2007;115:2418-25.CrossRef Peterson SE, Jerosch-Herold M, Hudsmith LE, Robson MD, Frances JM, Doll HA, et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 2007;115:2418-25.CrossRef
12.
go back to reference Ismail TF, Hsu L, Greve AM, Concalves C, Jabbour A, Gulati A, et al. Coronary microvascular ischemia in hypertrophic cardiomyopathy—a pixel-wise quantitative cardiovascular magnetic resonance perfusion study. J Cardiomagn Reson 2014;16:49. Ismail TF, Hsu L, Greve AM, Concalves C, Jabbour A, Gulati A, et al. Coronary microvascular ischemia in hypertrophic cardiomyopathy—a pixel-wise quantitative cardiovascular magnetic resonance perfusion study. J Cardiomagn Reson 2014;16:49.
13.
go back to reference Maron MS, Olivotto I, Maron BJ, Prasad SK, Cecchi F, Udelson JE, Camici PG. The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 2009;54:866-75.CrossRefPubMed Maron MS, Olivotto I, Maron BJ, Prasad SK, Cecchi F, Udelson JE, Camici PG. The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 2009;54:866-75.CrossRefPubMed
Metadata
Title
Why LV dilatation with vasodilator stress in hypertrophic cardiomyopathy?
Author
Richard C. Brunken, MD, FACC, FAHA, FASNC
Publication date
01-12-2016
Publisher
Springer US
Published in
Journal of Nuclear Cardiology / Issue 6/2016
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-015-0180-x

Other articles of this Issue 6/2016

Journal of Nuclear Cardiology 6/2016 Go to the issue